David Hung has bought stock on 2 days since Apr 2025
Director at NovoCure Limited, and 2 other companies
SEC CIK 0001310880 · Filings on SEC.gov ↗
David Hung's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
5 filings since Feb 2016, newest first
About David Hung
David Hung, M.D., is a person and a life sciences executive who has served as a director of Novocure Ltd. since May 2018.( He is currently the founder, president, and chief executive officer of Nuvation Bio Inc., and also serves on the board of several biotechnology companies, reflecting a career focused on oncology and biopharmaceutical leadership.(
Dr. Hung founded Medivation, Inc. in 2003 and led it as president and CEO until its acquisition by Pfizer in 2016; during his tenure, Medivation developed and commercialized XTANDI (enzalutamide), a major prostate cancer therapy.( Earlier in his career, he served as president and CEO of ProDuct Health, Inc. and held roles in research and development at Chiron Corporation.( He earned an M.D. from the University of California, San Francisco, School of Medicine and an A.B., summa cum laude, in biology from Harvard College.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.